|
Gilead Sciences Common
(GILD)
|
13.2 |
$282M |
|
2.7M |
106.45 |
|
Celgene Corporation Common
|
9.9 |
$210M |
|
2.2M |
94.78 |
|
Alexion Pharmaceuticals Common
|
3.7 |
$79M |
|
479k |
165.82 |
|
Vertex Pharmaceuticals Common
(VRTX)
|
3.7 |
$79M |
|
702k |
112.31 |
|
Amgen Common
(AMGN)
|
3.4 |
$72M |
|
510k |
140.46 |
|
Regeneron Pharmaceuticals Common
(REGN)
|
3.2 |
$68M |
|
187k |
360.52 |
|
Actavis Shares
|
3.1 |
$67M |
|
278k |
241.28 |
|
Biogen Idec Common
(BIIB)
|
3.1 |
$66M |
|
200k |
330.81 |
|
Incyte Corporation Common
(INCY)
|
2.8 |
$61M |
|
1.2M |
49.05 |
|
Pfizer Common
(PFE)
|
2.6 |
$56M |
|
1.9M |
29.57 |
|
BioMarin Pharmaceutical Common
(BMRN)
|
2.4 |
$51M |
|
711k |
72.16 |
|
Mylan Common
|
2.2 |
$46M |
|
1.0M |
45.49 |
|
Illumina Common
(ILMN)
|
1.9 |
$42M |
|
253k |
163.92 |
|
Allergan Common
|
1.9 |
$41M |
|
228k |
178.19 |
|
Teva Pharmaceutical Industries Common Call Option
(TEVA)
|
1.8 |
$39M |
|
721k |
53.75 |
|
Johnson & Johnson Common
(JNJ)
|
1.6 |
$35M |
|
327k |
106.59 |
|
Cubist Pharmaceuticals Common
|
1.5 |
$33M |
|
495k |
66.34 |
|
Thermo Fisher Scientific Common
(TMO)
|
1.5 |
$33M |
|
267k |
121.70 |
|
Shire Sponsored ADR
|
1.5 |
$32M |
|
123k |
259.05 |
|
Aetna Common
|
1.5 |
$32M |
|
389k |
81.00 |
|
Impax Laboratories Common
|
1.5 |
$31M |
|
1.3M |
23.71 |
|
Jazz Pharmaceuticals Shares
(JAZZ)
|
1.3 |
$28M |
|
173k |
160.56 |
|
AbbVie Common
(ABBV)
|
1.3 |
$28M |
|
481k |
57.76 |
|
Bristol-Myers Squibb Common
(BMY)
|
1.3 |
$27M |
|
535k |
51.18 |
|
Akorn Common
|
1.2 |
$25M |
|
699k |
36.27 |
|
Neurocrine Biosciences Common
(NBIX)
|
1.1 |
$25M |
|
1.6M |
15.67 |
|
Endo International Shares
|
1.1 |
$23M |
|
336k |
68.34 |
|
Ishares Nasdaq Biotechnology ETF Etf
(IBB)
|
1.0 |
$22M |
|
79k |
273.63 |
|
Alkermes Shares
(ALKS)
|
0.9 |
$19M |
|
437k |
42.87 |
|
Catamaran Corporation Common
|
0.9 |
$18M |
|
434k |
42.15 |
|
Synageva BioPharma Corp. Common
|
0.7 |
$15M |
|
223k |
68.78 |
|
Molina Healthcare Common
(MOH)
|
0.7 |
$15M |
|
348k |
42.30 |
|
Sarepta Therapeutics Common
(SRPT)
|
0.7 |
$15M |
|
691k |
21.10 |
|
McKesson Corporation Common
(MCK)
|
0.6 |
$13M |
|
68k |
194.67 |
|
Celldex Therapeutics Common
|
0.6 |
$13M |
|
1.0M |
12.96 |
|
Sagent Pharmaceuticals Common
|
0.6 |
$13M |
|
405k |
31.10 |
|
Eli Lilly & Co Common
(LLY)
|
0.6 |
$12M |
|
187k |
64.85 |
|
Momenta Pharmaceuticals Common
|
0.6 |
$12M |
|
1.1M |
11.34 |
|
Alere Common
|
0.5 |
$12M |
|
298k |
38.78 |
|
Health Care REIT Common (Principal)
|
0.5 |
$11M |
|
200k |
57.18 |
|
Cigna Corp Common
|
0.5 |
$11M |
|
122k |
90.69 |
|
Acorda Therapeutics Common
|
0.5 |
$11M |
|
321k |
33.88 |
|
bluebird Bio Common
|
0.5 |
$11M |
|
291k |
35.88 |
|
NPS Pharmaceuticals Common
|
0.5 |
$10M |
|
395k |
26.00 |
|
Ironwood Pharmaceuticals Common
(IRWD)
|
0.5 |
$10M |
|
768k |
12.95 |
|
Verastem Common
|
0.5 |
$9.8M |
|
1.1M |
8.52 |
|
Celladon Corporation Common
|
0.5 |
$9.6M |
|
971k |
9.94 |
|
Perrigo Company Shares
(PRGO)
|
0.4 |
$9.5M |
|
63k |
150.19 |
|
Physicians Realty Trust Common
|
0.4 |
$9.2M |
|
672k |
13.72 |
|
Infinity Pharmaceuticals Common
(INFIQ)
|
0.4 |
$9.1M |
|
681k |
13.42 |
|
LTC Properties Common
(LTC)
|
0.4 |
$8.7M |
|
237k |
36.89 |
|
Myriad Genetics Common
(MYGN)
|
0.4 |
$8.7M |
|
224k |
38.57 |
|
Omega Healthcare Investors Common
(OHI)
|
0.4 |
$8.6M |
|
253k |
34.19 |
|
BioDelivery Sciences International Common
|
0.4 |
$8.6M |
|
502k |
17.09 |
|
Senior Housing Properties Trust Shares
|
0.4 |
$8.6M |
|
410k |
20.92 |
|
Community Health Systems Common
(CYH)
|
0.4 |
$8.5M |
|
155k |
54.79 |
|
Ventas Common
(VTR)
|
0.4 |
$8.4M |
|
136k |
61.95 |
|
Sabra Health Care REIT Common
(SBRA)
|
0.4 |
$8.4M |
|
343k |
24.32 |
|
HCA Holdings Common
(HCA)
|
0.4 |
$8.2M |
|
116k |
70.52 |
|
Sangamo BioSciences Common
(SGMO)
|
0.4 |
$8.1M |
|
750k |
10.79 |
|
Nektar Therapeutics Common
|
0.4 |
$8.1M |
|
670k |
12.07 |
|
Zimmer Holdings Common
(ZBH)
|
0.4 |
$8.0M |
|
80k |
100.55 |
|
Stryker Corporation Common
(SYK)
|
0.4 |
$7.7M |
|
96k |
80.75 |
|
Medical Properties Trust Common
(MPT)
|
0.4 |
$7.7M |
|
627k |
12.26 |
|
St Jude Medical Common
|
0.3 |
$7.4M |
|
123k |
60.13 |
|
Heron Therapeutics Common
(HRTX)
|
0.3 |
$7.3M |
|
874k |
8.33 |
|
PerkinElmer Common
(RVTY)
|
0.3 |
$7.2M |
|
166k |
43.60 |
|
UnitedHealth Group Common
(UNH)
|
0.3 |
$7.2M |
|
83k |
86.25 |
|
IDEXX Laboratories Common
(IDXX)
|
0.3 |
$6.6M |
|
56k |
117.84 |
|
Amarin Corporation Sponsored ADR
|
0.3 |
$6.2M |
|
5.6M |
1.09 |
|
Endologix Common
|
0.3 |
$5.8M |
|
551k |
10.60 |
|
Corsicanto Note 3.5% 1/15/32 (Principal)
|
0.3 |
$5.8M |
|
8.7M |
0.67 |
|
WellCare Health Plans Common
|
0.3 |
$5.3M |
|
89k |
60.34 |
|
Accuray Common
(ARAY)
|
0.2 |
$5.3M |
|
732k |
7.26 |
|
Merrimack Pharmaceuticals Common
|
0.2 |
$5.0M |
|
568k |
8.78 |
|
Centene Corporation Common
(CNC)
|
0.2 |
$5.0M |
|
60k |
82.72 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
0.2 |
$4.8M |
|
62k |
78.11 |
|
Clovis Oncology Common
|
0.2 |
$4.7M |
|
104k |
45.36 |
|
IntelliPharmaceutics International Common
|
0.2 |
$4.2M |
|
1.4M |
3.01 |
|
Epizyme Common
|
0.2 |
$3.8M |
|
141k |
27.11 |
|
KYTHERA Biopharmaceuticals Common
|
0.2 |
$3.7M |
|
111k |
32.76 |
|
Align Technology Common
(ALGN)
|
0.2 |
$3.6M |
|
70k |
51.68 |
|
Karyopharm Therapeutics Common
|
0.2 |
$3.6M |
|
102k |
34.94 |
|
PTC Therapeutics Common
(PTCT)
|
0.2 |
$3.5M |
|
79k |
44.01 |
|
Ligand Pharmaceuticals Common
(LGND)
|
0.2 |
$3.3M |
|
69k |
46.99 |
|
Thoratec Corporation Common
|
0.1 |
$3.0M |
|
113k |
26.73 |
|
Merrimack Pharmaceuticals Note 4.50% 7/15/20 (Principal)
|
0.1 |
$2.3M |
|
1.5M |
1.55 |
|
Agios Pharmaceuticals Common
(AGIO)
|
0.1 |
$2.1M |
|
35k |
61.34 |
|
MEI Pharma Common
|
0.1 |
$1.7M |
|
244k |
6.90 |
|
Macrogenics Common
(MGNX)
|
0.0 |
$666k |
|
32k |
20.91 |
|
OncoGenex Pharmaceuticals Common
|
0.0 |
$302k |
|
113k |
2.67 |
|
Sage Therapeutics Common
(SAGE)
|
0.0 |
$158k |
|
5.0k |
31.60 |